• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[新辅助激素治疗后局限性前列腺肿瘤的组织学消退]

[Histologic regression of localized prostatic tumor with neoadjuvant hormonal therapy].

作者信息

López López C, Quilez Fenoll J M, Gómez Ruiz J J, López López A F, Romero Maroto Y J

机构信息

Servicio de Urología, Hospital Universitario San Juan, Alicante, España.

出版信息

Arch Esp Urol. 1996 Oct;49(8):819-23.

PMID:9065279
Abstract

OBJECTIVES

To determine the usefulness of preoperative hormone therapy in patients with organ-confined prostatic carcinoma undergoing radical prostatectomy.

METHODS

7 patients with localized prostatic carcinoma are presented. All patients were submitted to radical prostatectomy; 4 had been randomly selected for preoperative hormone therapy.

RESULTS

Histological examination showed no nodal involvement in all cases. The tumor could not be identified (Po) in two of the four patients who received hormone therapy. The other two patients were staged down; the Gleason score remained unchanged in one and increased in the other. The patients who did not receive preoperative hormone therapy showed concordant clinical and pathological stages, except one in whom infiltration of the prostatic capsule was observed. No difference was found concerning the facility in performing surgery between the treated and untreated patients.

CONCLUSIONS

Hormonal deprivation eliminated the tumor burden in two cases that might have been completely hormone sensitive, with no correlation in the pretreatment histological grade. Clinical downstaging is achieved by this treatment modality. However, further studies in larger series comparing the percentages of downstaging, histological downgrading, absence of tumor cells in the surgical specimen and impact on survivorship are warranted.

摘要

目的

确定术前激素治疗对接受根治性前列腺切除术的器官局限性前列腺癌患者的有效性。

方法

报告7例局限性前列腺癌患者。所有患者均接受了根治性前列腺切除术;其中4例被随机选择接受术前激素治疗。

结果

组织学检查显示所有病例均无淋巴结受累。在接受激素治疗的4例患者中,有2例未发现肿瘤(P0)。另外2例患者分期降低;其中1例患者的Gleason评分保持不变,另1例升高。未接受术前激素治疗的患者临床和病理分期一致,但有1例观察到前列腺包膜浸润。在接受治疗和未接受治疗的患者之间,手术操作的难易程度没有差异。

结论

激素剥夺消除了2例可能对激素完全敏感的患者的肿瘤负荷,与治疗前的组织学分级无关。通过这种治疗方式可实现临床分期降低。然而,有必要进行更大样本量的进一步研究,比较分期降低的百分比、组织学降级、手术标本中无肿瘤细胞的情况以及对生存率的影响。

相似文献

1
[Histologic regression of localized prostatic tumor with neoadjuvant hormonal therapy].[新辅助激素治疗后局限性前列腺肿瘤的组织学消退]
Arch Esp Urol. 1996 Oct;49(8):819-23.
2
Neoadjuvant hormonal deprivation before radical prostatectomy.根治性前列腺切除术前行新辅助激素剥夺治疗。
Clin Invest Med. 1993 Dec;16(6):523-31.
3
[Effect of complete androgen block before radical prostatectomy for cancer of the prostate].[前列腺癌根治性前列腺切除术前行完全雄激素阻断的效果]
Arch Esp Urol. 1997 May;50(4):355-63.
4
Histopathological effects of androgen deprivation in prostatic cancer.雄激素剥夺对前列腺癌的组织病理学影响。
Semin Urol Oncol. 1996 May;14(2 Suppl 2):22-31.
5
[The role of neoadjuvant treatment prior to radical prostatectomy].
Acta Urol Belg. 1992;60(3):61-71.
6
Update on Memorial Sloan-Kettering Cancer Center studies of neoadjuvant hormonal therapy for prostate cancer.纪念斯隆凯特琳癌症中心前列腺癌新辅助激素治疗研究进展
Mol Urol. 2000 Fall;4(3):241-8;discussion 249-50.
7
Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).雄激素剥夺疗法作为局限性前列腺癌的主要治疗方法:来自前列腺癌战略泌尿学研究计划(CaPSURE)的数据。
Cancer. 2006 Apr 15;106(8):1708-14. doi: 10.1002/cncr.21799.
8
Effect of neoadjuvant androgen deprivation on circulating prostate cells in the bone marrow of men undergoing radical prostatectomy.新辅助雄激素剥夺对接受根治性前列腺切除术男性骨髓中循环前列腺细胞的影响。
Clin Cancer Res. 1998 Sep;4(9):2119-23.
9
Androgen receptor modulation in benign human prostatic tissue and prostatic adenocarcinoma during neoadjuvant endocrine combination therapy.新辅助内分泌联合治疗期间良性人前列腺组织和前列腺腺癌中的雄激素受体调节
Prostate. 1996 Apr;28(4):227-31. doi: 10.1002/(SICI)1097-0045(199604)28:4<227::AID-PROS3>3.0.CO;2-A.
10
Does neoadjuvant hormone therapy improve outcome in prostate cancer patients receiving radiotherapy after radical prostatectomy?新辅助激素疗法能否改善前列腺癌患者在根治性前列腺切除术后接受放疗的预后?
Can J Urol. 2009 Apr;16(2):4541-52.